Mario Martín-Sánchez

Also affiliated with European Centre for Disease Prevention and Control

MedicineMathematicsAgricultural and Biological SciencesImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial”.

Comparative antibody and cell-mediated immune responses, reactogenicity, and efficacy of homologous and heterologous boosting with CoronaVac and BNT162b2 (Cobovax): an open-label, randomised trial

The Lancet Microbe(2023)10.1016/s2666-5247(23)00216-1

N/A

0.749DataRank · unranked

25 citations

Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk +17 more

Homologous and heterologous boosting with CoronaVac and BNT162b2: a randomized trial (the Cobovax study)

medRxiv(2022)10.1101/2022.08.25.22279158

N/A

0DataRank · unranked

4 citations

Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk +17 more